{"organizations": [], "uuid": "96f1830e1a8af1826a8cf66e0a790c59f1de1e89", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/finance/markets/us", "section_title": "US Stock Market News - Dow Jones, Nasdaq, S&amp;P 500 | Reuters.com", "url": "https://www.reuters.com/article/brief-shire-says-granted-eu-marketing-au/brief-shire-says-granted-eu-marketing-authorization-for-adynovi-for-adults-and-adolescents-with-hemophilia-a-idUSFWN1PA00V", "country": "US", "domain_rank": 408, "title": "BRIEF-Shire Says Granted EU marketing Authorization For ADYNOVI For Adults And Adolescents With Hemophilia A", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.869, "site_type": "news", "published": "2018-01-15T15:24:00.000+02:00", "replies_count": 0, "uuid": "96f1830e1a8af1826a8cf66e0a790c59f1de1e89"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-shire-says-granted-eu-marketing-au/brief-shire-says-granted-eu-marketing-authorization-for-adynovi-for-adults-and-adolescents-with-hemophilia-a-idUSFWN1PA00V", "ord_in_thread": 0, "title": "BRIEF-Shire Says Granted EU marketing Authorization For ADYNOVI For Adults And Adolescents With Hemophilia A", "locations": [], "entities": {"persons": [], "locations": [{"name": "liechtenstein", "sentiment": "none"}, {"name": "norway", "sentiment": "none"}, {"name": "iceland", "sentiment": "none"}], "organizations": [{"name": "eu", "sentiment": "negative"}, {"name": "shire plc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "shire", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 15, 2018 / 7:24 AM / Updated 30 minutes ago BRIEF-Shire Says Granted EU marketing Authorization For ADYNOVI For Adults And Adolescents With Hemophilia A Reuters Staff 1 Min Read \nJan 15 (Reuters) - Shire Plc: \n* SHIRE GRANTED EU MARKETING AUTHORIZATION FOR ADYNOVI [ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED] FOR ADULTS AND ADOLESCENTS WITH HEMOPHILIA A​ \n* ‍SHIRE IS NOW AUTHORIZED TO MARKET ADYNOVI IN 28 MEMBER STATES OF EUROPEAN UNION (EU), AS WELL AS IN ICELAND, LIECHTENSTEIN AND NORWAY​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-15T15:24:00.000+02:00", "crawled": "2018-01-15T09:37:55.006+02:00", "highlightTitle": ""}